[Retracted] Meta-Analysis of the Effectiveness and Safety of Glucocorticoid for the Treatment of IgA Kidney Disease

Table 6

Effect of glucocorticoid on IgA nephropathy proteinuria with blood creatinine level less than 1.50 mg/dl.

Glucocorticoid group				Control group			Std. mean difference
Study or subgroup	Mean	SD	Total	Mean	SD	Total	Weight	IV, fixed, 95% CI
Shoji et al., 2000	0.29	0.23	11	0.71	0.39	8	4.9%	−1.31 [−2.33,−0.29]
Locatelli et al., 2001	0.67	0.5	43	1.48	1.87	43	27.7%	−0.59 [−1.02,−0.15]
Uzu et al., 2003	−1.26	0.56	23	−0.86	0.45	22	14.0%	−0.77 [−1.38,−0.16]
Moriyama et al., 2004	1.02	0.98	20	1.28	2.19	40	17.9%	−0.14 [−0.67, 0.40]
Hogg et al., 2006	−1.26	0.56	34	−0.86	0.45	31	20.2%	−0.77 [−1.28, −0.27]
Koike et al., 2008	0.31	0.51	24	0.68	0.69	24	15.4%	−0.60 [−1.18, −0.02]
Total (95% CI)			155			168	100.0%	−0.61 [−0.83, −0.38]

Heterogeneity: Chi’ = 5.47, df = 5 ( = 0.36); F = 9%. Test for overall effect: Z = 5.24 (＜0.00001).